Antinuclear antibody and rheumatoid factor positivity in temporomandibular disorders

Head & Face Medicine

Table 5 Correlations among hematological and pain-related indices in male temporomandibular disorders patients

	Pain duration	Pain intensity	Disability days	NRS before	CMO	MMO	Capsule palpation	Muscle palpation -masticatory	Muscle palpation-neck	CMO6	MMO6
WBC (10³/ul)	−0.240	0.069	0.106	0.110	−0.071	−0.022	0.259	−0.182	− 0.011	−0.031	− 0.067
RBC (10⁶/ul)	0.073	−0.297^*	− 0.260	−0.402^**	0.365^**	0.267	−0.143	− 0.262	−0.393^**	0.323^*	0.331^*
Hemoglobin(g/dl)	0.087	−0.130	0.040	−0.228	0.249	0.248	−0.191	−0.208	− 0.140	0.264	0.303^*
Platelet (10³/ul)	0.020	0.008	−0.009	0.081	−0.088	−0.016	− 0.110	−0.215	− 0185	0.081	0.033
ESR (mm/hr)	−0.279^*	0.132	−0.039	0.297^*	− 0.175	−0.155	0.082	−0.061	0.091	−0.130	− 0.163
CRP (mg/dl)	−0.207	0.226	0.040	0.417^**	− 0.217	−0.097	0.006	0.020	0.202	−0.066	−0.075

NRS before numeric rating scale score before treatment initiation, CMO comfortable mouth opening, MMO maximum mouth opening, Palpation number of muscle that showed a positive response on palpation, CMO6 CMO following 6 months of treatment, MMO6 MMO following 6 months of treatment, WBC white blood cell, RBC red blood cell, ESR erythrocyte sedimentation rate, CRP C-reactive protein
Pain intensity scores were calculated based on answers to the RDC/TMD Axis II questionnaire (mean score of question #7, 8, 9*10)
^*Significant difference: p < 0.05
^**Significant difference: p < 0.01

ISSN: 1746-160X